Description

The NextSeq Series leverages the latest evolution of Illumina sequencing by synthesis (SBS) technology, two-channel SBS, enabling a breakthrough reduction in data generation times.



SBS is the proven, highly accurate reversible-terminator technology used by all Illumina sequencing platforms. The technology uses fluorescently labeled nucleotides to sequence hundreds of millions of clusters on a flow cell surface in parallel. The method virtually eliminates errors and missed calls associated with strings of repeated nucleotides (homopolymers). Benefits of the New Two-Channel SBS Technology



Leveraging all the benefits of proven Illumina SBS chemistry, two-channel SBS technology on the NextSeq Series offers: Faster sequencing times Faster data generation with high data accuracy An affordable solution, enabling NGS to become an everyday tool in laboratories worldwide



Contact: genomics@ncl.ac.uk



https://www.ncl.ac.uk/gcf/

ManufacturerIllumina Cambridge Ltd

ModelNextSeq 500

Contact

Academic Contact

Jon Coxhead
jonathan.coxhead@ncl.ac.uk